Departmental Publications


2011 Publications


AUTOPSY

  1. Roberts WC, Varughese CA, Ko JM, Grayburn PA, Hebeler RF Jr, Burton EC. Carcinoid heart disease without the carcinoid syndrome but with quadrivalvular regurgitation and unsuccessful operative intervention. Am J Cardiol 2011 Mar1;107(5):788-92.

CARDIOVASCULAR PATHOLOGY

  1. Jain D, Dietz HC, Oswald GL, Maleszewski JJ, Halushka MK. Causes and histopathology of ascending aortic disease in children and young adults. Cardiovasc Pathol 2011 Jan-Feb;20(1):15-25.
  2. Jain D, Fishman EK, Argani P, Shah AS, Halushka MK. Unexpected sclerosing mediastinitis involving the ascending aorta in the setting of a multifocal fibrosclerotic disorder. Pathol Res Pract 2011 Jan 15;207(1):60-2.
  3. Kohr MJ, Sun J, Aponte A, Wang G, Gucek M, Murphy E, Steenbergen C. Simultaneous measurement of protein oxidation and S-nitrosylation during preconditioning and ischemia/reperfusion injury with resin-assisted capture. Circ Res 2011 Feb;108(4):418-26.
  4. Kohr MJ, Aponte AM, Sun J, Wang G, Murphy E, Gucek M, Steenbergen C. Characterization of potential S-nitrosylation sites in the myocardium. Am J Physiol Heart Circ Physiol 2011 Apr;300(4):H1327-35.
  5. Kucirka LM, Maleszewski JJ, Segev DL, Halushka MK. Survey of North American pathologist practices regarding antibody-mediated rejection in cardiac transplant biopsies. Cardiovasc Pathol. 2011 May-Jun;20(3):132-8.
  6. Maleszewski JJ, Kucirka LM, Segev DL, Halushka MK. Survey of current practice related to grading of rejection in cardiac transplant recipients in North America. Cardiovasc Pathol 2011 Sep-Oct;20(5):261-5.
  7. McCall MN, Kent OA, Yu J, Fox-Talbot K, Zaiman AL, Halushka MK. MicroRNA profiling of diverse endothelial cell types. BMC Med Genomics 2011 Nov 2;4(1):78.
  8. Murphy E, Lagranha C, Deschamps A, Kohr M, Nguyen T, Wong R, Sun J, Steenbergen C. Mechanisms of cardioprotection: what can we learn from females? Pediatr Cardiol 2011 Mar;32(3):354-9.

CLINICAL CHEMISTRY

  1. Baycin-Hizal D, Tian Y, Akan I, Jacobson E, Clark D, Wu A, Jampol R, Palter K, Betenbaugh M, Zhang H. GlycoFish: a database of zebrafish N-linked glycoproteins identified using SPEG method coupled with LC/MS. Anal Chem 2011 July;83:5296-303.
  2. Chan DW. Exciting news from Clinical Proteomics. Clin Proteomics 2011 May; 31;8(1):3.
  3. Henemyre-Harris CL, Sakuda LS. Communicating change to laboratory customers. Lab Medicine 2011 July;42(7):403-9.
  4. Li Y, Tao SC, Bova GS, Liu AY, Chan DW, Zhu H, Zhang H. Detection and verification of glycosylation patterns of glycoproteins from clinical specimens using lectin microarrays and lectin-based immunosorbent assays. Anal Chem 2011 Nov;83:8509-16.
  5. Li Y, Tian Y, Rezai T, Prakash A, Lopez MF, Chan DW, Zhang H. Simultaneous analysis of glycosylated and sialylated PSA reveals differential distribution of glycosylated PSA isoforms in prostate cancer tissues. Anal Chem 2011 Jan;83(1):240-5.
  6. Meany DL, Chan DW. Aberrant glycosylation associated with enzymes as cancer biomarkers. Clin Proteomics 2011 Jun 3;8(1):7.
  7. Meany DL, Hackler L Jr, Zhang H, Chan DW. Tyramide signal amplification for antibody-overlay lectin microarray: a strategy to improve the sensitivity of targeted glycan profiling. J Proteome Res. 2011 Mar 4;10(3):1425-31.
  8. Sokoll LJ, Rosenwald S, Lyons J, Elliott DJ, Chan DW. Is the WHO 90:10 prostate specific antigen (PSA) first international standard really 90% α1-anticymotrypsin-bound PSA and 10% free PSA? Clin Chem 2011 Dec;57(12):1776-7.
  9. Tian Y, Bova GS, Zhang H. Quantitative glycoproteomic analysis of optimal cutting temperature-embedded frozen tissues identifying glycoproteins associated with aggressive prostate cancer. Anal Chem 2011 Sept;83(18):7013–9.
  10. Tian Y, Roden R, Zhang H. Glycoproteins associated with different histological subtypes of ovarian tumors. Proteomics 2011 Dec;11(24):4677-87.

CYTOPATHOLOGY

  1. Bishop JA, Ali SZ. Hyalinizing trabecular adenoma of the thyroid gland. Diagn Cytopathol 2011 Apr;39(4):306-10.
  2. Bishop JA, Hosler GA, Kulesza P, Erozan YS, Ali SZ. Fine-needle aspiration of renal cell carcinoma: is accurate Fuhrman grading possible on cytologic material? Diagn Cytopathol 2011 Mar;39(3):168-71.
  3. Bishop JA, Shum CH, Sheth S, Wakely PE Jr, Ali SZ. Small cell osteosarcoma: cytopathologic characteristics and differential diagnosis. Am J Clin Pathol 2010 May;133(5):756-61.
  4. Cimino-Mathews A, Ali SZ. Metastatic urothelial carcinoma with signet ring features: cytomorphologic findings in abdominal paracentesis. Diagn Cytopathol 2011 Feb;39(2):132-4.
  5. Cimino-Mathews A, Illei PB, Ali SZ. Atypical granular cell tumor of the thyroid: cytomorphologic features on fine needle aspiration. Diagn Cytopathol 2011 Aug;39(8):608-11.
  6. Singhi AD, Hruban RH, Fabre M, Imura J, Schulick R, Wolfgang C, Ali SZ. Peripancreatic paraganglioma: a potential diagnostic challenge in cytopathology and surgical pathology. Am J Surg Pathol 2011 Oct;35(10):1498-504.
  7. Stoll LM, Li QK. Cytology of fine needle aspiration of inflammatory myofibroblastic tumor (IMT). Diagn Cytopathol. 2011 Sept;39:663-72.

GI / LIVER PATHOLOGY

  1. Bisht S, Mizuma M, Feldmann G, Ottenhof NA, Hong SM, Pramanik D, Chenna V, Karikari C, Sharma R, Goggins MG, Rudek MA, Ravi R, Maitra A, Maitra A. Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. Mol Cancer Ther 2010 Aug;9(8):2255-64.
  2. Goggins M. Markers of pancreatic cancer: working toward early detection. Clin Cancer Res 2011 Feb 15;17(4):635-7.
  3. Handra-Luca A, Montgomery E. Vascular malformations and hemangiolymphangiomas of the gastrointestinal tract: morphological features and clinical impact. Int J Clin Exp Pathol 2011 Jun 20;4(5):430-43.
  4. Hong SM, Heaphy CM, Shi C, Eo SH, Cho H, Meeker AK, Eshleman JR, Hruban RH, Goggins M. Telomeres are shortened in acinar-to-ductal metaplasia lesions associated with pancreatic intraepithelial neoplasia but not in isolated acinar-to-ductal metaplasias. Mod Pathol 2011 Feb;24(2):256-66.
  5. Lam-Himlin D, Arnold CA, Montgomery EA. Histopathology of Iatrogenic injury in the colorectum. Diagnostic Histopathology 2011 Sept;17(9):404-8.
  6. Lam-Himlin D, Montgomery EA. The neoplastic appendix: a practical approach. Diagnostic Histopathology 2011;17(9):395-403.
  7. Lam-Himlin D, Tsiatis AC, Montgomery E, Pai RK, Brown JA, Razavi M, Lamps L, Eshleman JR, Bhagavan B, Anders RA. Sarcina organisms in the gastrointestinal tract: a clinicopathologic and molecular study. Am J Surg Pathol. 2011 Nov;35(11):1700-5.
  8. Matsubayashi H, Hasuike N, Onozawa Y, Knemoto H, Ono H, Hruban RH. Autoimmune pancreatitis with response to chemoradiation therapy. J Gastrointestin Liver Dis 2011 Sept;3:315-9.
  9. Matthaei H, Schulick RD, Hruban RH, Maitra A. Cystic precursors to invasive pancreatic cancer. Nat Rev Gastroenterol Hepatol 2011 Mar;8(3):141-50.
  10. Meriden Z, Shi C, Edil BH, Ellison T, Wolfgang CL, Cornish TC, Schulick RD, Hruban RH. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis. Am J Surg Pathol. 2011 Jul;35(7):981-8.
  11. Montgomery E. Pattern approach to soft tissue tumors. Clinics in Surgical Pathol 2011 Sept;4(3):ix.
  12. Pramanik D, Campbell NR, Karikari C, Chivukula R, Kent OA, Mendell JT, Maitra A. Restitution of tumor suppressor microRNAs using a systemic nanovector inhibits pancreatic cancer growth in mice. Mol Cancer Ther 2011 Aug;10(8):1470-80.
  13. Ross HM, Daniel HD, Vivekanandan P, Kannangai R, Yeh MM, Wu TT, Makhlouf HR, Torbenson M. Fibrolamellar carcinomas are positive for CD68. Mod Pathol 2011 Mar;24(3):390-5.
  14. Ryu JK, Matthaei H, Dal Molin M, Hong SM, Canto MI, Schulick RD, Wolfgang C, Goggins MG, Hruban RH, Cope L, Maitra A. Elevated microRNA miR-21 levels in pancreatic cyst fluid are predictive of mucinous precursor lesions of ductal adenocarcinoma. Pancreatology 2011 Sept;11(3):343-50.
  15. Salih KH, Singhi AD, Montgomery E. Selected lesions featuring giant cells. Clinics in Surgical Pathol 2011Sept;4:887-913.
  16. Singhi AD, Maklouf HR, Mehrotra AK, Goodman ZD, Drebber U, Dienes HP, Torbenson M. Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances. Am J Surg Pathol 2011 Mar;35(3):364-71.
  17. Singhi AD, Montgomery EA. Gastrointestinal tract langerhans cell histiocytosis: a clinicopathologic study of 12 patients. Am J Surg Pathol 2011 Feb;35(2):305-10.
  18. Singhi AD, Montgomery E. Liposarcomas. Clinics in Surgical Pathol 2011 Sept;4:963-94.
  19. Torbenson, MS. Iron in the liver: A review for surgical pathologists. Adv Anat Pathol. 2011 Jul;18(4):306-17.
  20. Voltaggio L, Montgomery EA. Histopathology of Barrett esophagus. Diagnostic Histopathology 2011;17(2):41-9.
  21. Yachida S, Zhong Y, Patrascu R, Davis MB, Morsberger LA, Griffin CA, Hruban RH, Laheru D, Iacobuzio-Donahue CA. Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas. Pancreas 2011 Aug;40(6):905-10.
  22. Zhong Y, Wang Z, Fu B, Pan F, Yachida S, Dhara M, Albesiano E, Li L, Naito Y, Vilardell F, Cummings C, Martinelli P, Li A, Yonescu R, Ma Q, Griffin CA, Real FX, Iacobuzio-Donahue CA. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist dickkopf-1. PLoS One 2011;6(7):e22129.
  23. Zulifqar MI, Sheikh U, Montgomery E. Myxoid neoplasms. Clinics in Surgical Pathol 2011Sept;4:843-64.

GENITOURINARY PATHOLOGY

  1. Al Hussain T, Carter HB, Epstein JI. Significance of prostate adenocarcinoma perineural invasion on biopsy in patients who are otherwise candidates for active surveillance. J Urol 2011 Aug;186:470-3.
  2. Al Hussain TO, Epstein JI. Initial high grade prostatic intraepithelial neoplasia (HGPIN) with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy. Am J Surg Pathol 2011 Aug;35:1165-7.
  3. Amin A, Epstein JI. Pathological stage of prostatic ductal adenocarcinoma at radical prostatectomy: affect of percentage of the ductal component and associated grade of acinar adenocarcinoma. Am J Surg Pathol 2011 Apr;35:615-9.
  4. Amin A, Partin AW, Epstein JI. Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy. J Urol 2011 Oct; 186:1286-90.
  5. Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, Burger PC, Netto GJ. PAX2(-)/PAX8(-)/Inhibin A(+) Immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol 2011 Feb;35(2):262-7.
  6. Chaux A, Albadine R, Toubaji A, Hicks J, Meeker A, Platz EA, De Marzo AM, Netto GJ. Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas. Am J Surg Pathol 2011 Jul;35(7):1014-20.
  7. Chaux A, Pfannl R, RodrÄ‚­guez IM, Barreto JE, Velazquez EF, Lezcano C, Piris A, Netto GJ, Cubilla AL. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol 2011 Apr;35(4):553-62.
  8. Chen Y, Epstein JI. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clininopathologic study of 7 cases. Am J Surg Pathol 2011 Mar;35:442-6.
  9. Chen Y, Fine SW, Epstein JI. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy. Am J Surg Pathol 2011 July;35:1054-61.
  10. Cimino-Mathews A, Sharma R, Netto GJ. Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid. Am J Surg Pathol 2011 May;35(5):757-61.
  11. Cox R, Epstein JI. Large nested variant of urothelial carcinoma: 23 cases of a newly described entity mimicking von brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Am J Surg Pathol 2011 Sept;35:1337-42.
  12. Ellis CL, Banerjee P, Carney E, Sharma R, Netto GJ. Adrenal lymphangioma: clinicopathologic and immunohistochemical characteristics of a rare lesion. Hum Pathol 2011 Jul;42(7):1013-8.
  13. Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011 Sept;186:790-7.
  14. Epstein JI. Update on the Gleason grading system. Annales de Pathologie 2011 Nov;31:S20-6.
  15. Fajardo DA, Miyamoto H, Miller JS, Lee TK, Epstein JI. Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology. Am J Surg Pathol 2011 Nov;35(11):1706-11.
  16. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, Bettegowda C, Rodriguez FJ, Eberhart CG, Hebbar S, Offerhaus GJ, McLendon R, Rasheed BA, He Y, Yan H, Bigner DD, Oba-Shinjo SM, Marie SK, Riggins GJ, Kinzler KW, Vogelstein B, Hruban RH, Maitra A, Papadopoulos N, Meeker AK. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011 Jul 22;333(6041):425.
  17. Heaphy CM, Meeker AK. The potential utility of telomere-related markers for cancer diagnosis. J Cell Mol Med 2011 Jun;15(6):1227-38.
  18. Heaphy CM, Subhawong AP, Gross AL, Konishi Y, Kouprina N, Argani P, Visvanathan K, Meeker AK. Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Mod Pathol 2011 Feb;24(2):194-200.
  19. Heaphy CM, Subhawong AP, Hong SM, Goggins MG, Montgomery EA, Gabrielson E, Netto GJ, Epstein JI, Lotan TL, Westra WH, Shih IeM, Iacobuzio-Donahue CA, Maitra A, Li QK, Eberhart CG, Taube JM, Rakheja D, Kurman RJ, Wu TC, Roden RB, Argani P, De Marzo AM, Terracciano L, Torbenson M, Meeker AK. Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes. Am J Pathol. 2011 Oct;179(4):1608-15.
  20. Karram S, Trock BJ, Netto GJ, Epstein JI. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy: correlation with radical prostatectomy findings. Am J Surg Pathol 2011 Sept;35:1351-5.
  21. Kryvenko ON, Gupta NS, Meier FA, Lee MW, Epstein JI. Anatomosing hemangioma of the genitourinary system: 8 cases in the kidney and ovary with immunohistochemical and ultrastructural analysis. AJCP 2011 Sept;136:450-7.
  22. Lee TK, Chaux A, Karram S, Miyamoto H, Miller JS, Fajardo DA, Epstein JI, Netto GJ. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Hum Pathol 2011 Nov;42(11):1799-803.
  23. Ling S, Chang X, Schultz L, Lee TK, Chaux A, Marchionni L, Netto GJ, Sidransky D, Berman DM. An EGFR-ERK-SOX9 signaling cascade links urothelial development and regeneration to cancer. Cancer Res 2011 Jun;71(11):3812-21.
  24. Lotan TL, Gupta NS, Wang W, Toubaji A, Haffner MC, Chaux A, Hicks JL, Meeker AK, Bieberich CJ, De Marzo AM, Epstein JI, Netto GJ. ERG gene rearrangements are common in prostatic small cell carcinomas. Mod Pathol 2011Jun;24(6):820-8.
  25. Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM. PTEN protein loss by immunostaining: analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res 2011 Oct 15;17(20):6563-73.
  26. Nagar M, Epstein JI. Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP). Am J Surg Pathol 2011 June;35:898-903.
  27. Netto GJ. Molecular diagnostics in urologic malignancies: a work in progress. Arch Pathol Lab Med 2011 May;135(5):610-21.
  28. Netto GJ. Tumor volume threshold of insignificant prostate cancer--was Dr.Stamey right all along? J Urol 2011 Jan;185(1):10-1.
  29. Netto GJ, Eisenberger M, Epstein JI. Interobserver variability of histologic evaluation of radical prostatectomy between central and local pathologists: findings of TAX 3501 multinational clinical trial. Urology 2011 May;77:1155-60.
  30. Schultz L, Chaux A, Albadine R, Hicks J, Kim JJ, De Marzo AM, Allaf ME,Carducci MA, Rodriguez R, Hammers HJ, Argani P, Reuter VE, Netto GJ. Immunoexpression status and prognostic value of mTOR and hypoxia-induced pathway members in primary and metastatic clear cell renal cell carcinomas. Am J Surg Pathol 2011 Oct;35(10):1549-56.
  31. Sfanos KS, Aloia AL, Hicks JL, Esopi DM, Steranka JP, Shao W, Sanchez-Martinez S, Yegnasubramanian S, Burns KH, Rein A, De Marzo AM. Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One 2011 June;6(6):e20874.
  32. Sfanos KS, Isaacs JT. The "infectious" nature of human prostate cancer: a cautionary note. Oncotarget 2011 Apr;2(4):281-3.
  33. Singh AK, Racusen LC. ASN clinicopathologic conference. Clin J Am Soc Nephrol 2011 Nov;6(11):2722-8.
  34. Tan PH, Cheng L, Srigley JR, Griffiths D, Humphrey PA, van der Kwast TH, Montironi R, Wheeler TM, Delahunt B, Egevad L, Epstein JI. ISUP Prostate Cancer Group. International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens. Working group 5. Surgical margins. Mod Pathol 2011Jan:24:48-57.
  35. Toubaji A, Albadine R, Meeker AK, Isaacs WB, Lotan T, Haffner MC, Chaux A, Epstein JI, Han M, Walsh PC, Partin AW, De Marzo AM, Platz EA, Netto GJ. Increased gene copy number of ERG on chromosome 21 but not TMPRSS2-ERG fusion predicts outcome in prostatic adenocarcinomas. Mod Pathol 2011 Nov;24(11):1511-20.

GYNECOLOGIC PATHOLOGY

  1. Guan B, Mao TL, Panuganti PK, Kuhn E, Kurman RJ, Maeda D, Chen E, Jeng YM, Wang TL, Shih IeM. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma. Am J Surg Pathol 2011 May;35(5):625-32.
  2. Davidson B, Holth A, Moripen L, Trope' CG, Shih IeM. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome. Hum Pathol 2011 Jul;42(7):991-7.
  3. DeScipio C, Haley L, Beierl K, Pandit AP, Murphy KM, Ronnett BM. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 2011 Oct;35(10):1586-91.
  4. Guan B, Wang TL, Shih IeM. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Res 2011 Nov;71(21):6718-27.
  5. Kang TH, Monie A, Wu LS, Pang X, Hung CF, Wu TC. Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. Vaccine. 2011 Jan 29;29(5):1082-9.
  6. Kuhn E, Meeker AK, Visvanathan K, Gross AL, Wang TL, Kurman RJ, Shih IeM. Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma. Mod Pathol 2011 Aug;24(8):1139-45.
  7. Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum Pathol 2011 Jul;42(7):918-31.
  8. Kurman RJ, Vang R, Junge J, Hannibal CG, Kjaer SK, Shih IeM. Papillary tubal hyperplasia: the putative precursor of ovarian atypical proliferative (borderline) serous tumors, noninvasive implants, and endosalpingiosis. Am J Surg Pathol 2011 Nov;35(11):1605-14.
  9. Meriden Z, Yemelyanova AY, Vang R, Ronnett BM. Ovarian metastases of pancreaticobiliary tract adenocarcinomas: analysis of 35 cases, with emphasis on the ability of metastases to simulate primary ovarian mucinous tumors. Am J Surg Pathol 2011 Feb;35(2):276-88.
  10. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol 2011 Mar;30(2):101-16.
  11. Olson MT, Gocke CD, Giuntoli RL 2nd, Shih IeM. Evolution of a trophoblastic tumor from an endometrioid carcinoma--a morphological and molecular analysis. Int J Gynecol Pathol 2011 Mar;30(2):117-20.
  12. Peng S, Ma B, Chen SH, Hung C-F, Wu TC. DNA vaccines delivered by human papillomavirus pseudovirions as a promising approach for generating antigen-specific CD8+ T cell immunity. Cell Biosci 2011 Jul 281(1):26.
  13. Peng S, Monie A, Pang X, Hung CF, Wu TC. Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines. J Biomed Sci 2011 Mar 8;18:21.
  14. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gyn Pathol 2011 Mar;30(2):101-16.
  15. Shih IeM. Trophoblastic vasculogenic mimicry in gestational choriocarcinoma. Mod Pathol 2011 May;24(5):646-52.
  16. Shih IeM, Nakayama K, Wu G, Nakayama N, Zhang J, Wang TL. Amplification of the ch19p13.2 NACC1 locus in ovarian high-grade serous carcinoma. Mod Pathol 2011 May;24(5):638-45.
  17. Shih IeM, Panuganti PK, Kuo KT, Mao TL, Kuhn E, Jones S, Velculescu VE, Kurman RJ, Wang TL. Somatic mutations of PPP2R1A in ovarian and uterine carcinomas. Am J Pathol 2011 Apr;178(4):1442-7.
  18. Seidman JD, Yemelyanova A, Zaino RJ, Kurman RJ. The fallopian tube-peritoneal junction: a potential site of carcinogenesis. Int J Gyn Pathol 2011 Jan;3(1):4-11.

HEMATOLOGIC PATHOLOGY

  1. Bowman WP, Larsen EL, Devidas M, Linda SB, Blach L, Carroll AJ, Carroll WL, Pullen DJ, Shuster J, Willman CL, Winick N, Camitta BM, Hunger SP, Borowitz MJ. Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906. Pediatr Blood Cancer 2011 Oct;57(4):569-77.
  2. Emadi A, Le A, Harwood CJ, Stagliano KW, Kamangar F, Ross AE, Cooper CR, Dang CV, Karp JE, Vuica-Ross M. Metabolic and electrochemical mechanisms of dimeric naphthoquinones cytotoxicity in breast cancer cells. Bioorg Med Chem 2011 Dec 1;19(23):7057-62.
  3. Hristov AC, Vonderheid EC, Borowitz MJ. Simplified flow cytometric assessment in mycosis fungoides and Sézary syndrome. Am J Clin Pathol 2011 Dec;136(6):944-53.
  4. Ross AE, Emadi A, Marchionni L, Hurley PJ, Simons BW, Schaeffer EM, Vuica-Ross M. Dimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicity. BJU Int 2011 Aug;108(3):447-54.
  5. Zheng R, Bailey E, Nguyen B, Yang X, Piloto O, Levis M, Small D. Further activation of FLT3 mutants by FLT3 ligand. Oncogene 2011 Sep 22;30(38):4004-14.
  6. Wahba L, Amon JD, Koshland D, Vuica-Ross M. RNase H and multiple RNA biogenesis factors cooperate to prevent RNA:DNA hybrids from generating genome instability. Mol Cell 2011 Dec 23;44(6):978-88.

IMMUNOLOGY

  1. Amukele TK, Baird GS, Chandler WL. Reducing the use of coagulation test panels. Blood Coagul Fibrinolysis 2011 Dec;22(8):688-95.
  2. Chiu Y, Schneck JP, Oelke M. HLA-Ig based artificial antigen presenting cells for efficient ex vivo expansion of human CTL. J Vis Exp 2011 Apr;50.
  3. Dalai SK, Khoruzhenko S, Drake CG, Jie CC, Sadegh-Nasseri S. Resolution of infection promotes a state of dormancy and long survival of CD4 memory T cells. Immuno and Cell Biol 2011 Nov;89:870-81.
  4. Guaraldi F, Salvatori R. Familial isolated pituitary adenomas: from genetics to therapy. Clin Transl Sci 2011 Feb;4(1):55-62.
  5. Hutfless S, Matos P, Talor MV, Caturegli P, Rose NR. Significance of prediagnositic thyroid antibodies in women with autoimmune thyroid disease. J Clin Endocrinol Metab 2011 Sep;96(9):E1466-71.
  6. Lee MT, Caturegli P, Humphrey RL, Thompson RE, Detrick B. Gamma/ IgG ratio: role in distinguishing monoclonal spikes from fibrinogen. J Clin Lab Anal Sept 2011;25(5):332-6.
  7. Lee JB, Oelke M, Ramachandra L, Canaday DH, Schneck JP. Decline of influenza-specific CD8+ T cell repertoire in healthy geriatric donors. Immun Ageing 2011 Aug 16;8:6.
  8. Li Y, Tao SC, Zhu H, Schneck JP. High-throughput lectin microarray-based analysis of live cell surface glycosylation. Curr Protoc Protein Sci. 2011 Feb;Chapter 12:Unit12.9.
  9. Morrell CN, Srivastava K, Swaim AM, Lee MT, Hooks JJ, Detrick B. Beta interferon suppresses the development of experimental cerebral malaria. Infection and Immunity 2011 Apr;79(4):1750-8.
  10. Rose NR. Conjugate vaccines and autism. Medical Hypothesis 2011 Dec;77(6):937-9.
  11. Rose NR. Critical cytokine pathways to cardiac inflammation. J Interferon Cytokine Res 2011 Oct;31(10):705-10.
  12. Rose NR. The genetics of autoimmune thyroiditis: the first decade. J Autoimmun 2011 Sep;37(2):88-94.
  13. Wasowska BA. Cross-talk between innate and adaptive immune responses in infection, transplant and autoimmune models. Curr Op in Organ Transplant 2011 Feb;16(1):1-6.
  14. Xing D, Liu L, Marti GP, Zhang X, Reinblatt M, Milner SM, Harmon JW. Hypoxia and hypoxia-inducible factor in the burn wound. Wound Repair Regen.2011 Mar-Apr;19(2):205-13.

INFORMATICS

  1. Ning G, Bi Y, Wang T, Xu M, Xu Y, Huang Y, Li M, Li X, Wang W, Chen Y, Wu Y, Hou J, Song A, Liu Y, Lai S. Relationship of urinary bisphenol. A concentration to risk for prevalent type 2 diabetes in Chinese adults: a cross-sectional analysis. Ann Intern Med 2011 Sep 20;155(6):368-74.

MEDICAL MICROBIOLOGY

  1. Carroll KC. Tests for the diagnosis of Clostridium difficile infection: the next generation. Anaerobe 2011 Aug;17:170-4.
  2. Forman M, Wilson A, Valsamakis A. Cytomegalovirus DNA quantification using an automated platform for nucleic acid extraction and real-time PCR assay setup. J Clin Microbiol 2011 Jul;49(7):2703-5.
  3. Grab DJ, Chakravorty SJ, van der Heyde H, Stins MF. How can microbial interactions with the blood-brain barrier modulate astroglial and neuronal function? Cell Microbiol 2011 Oct;13(10):1470-8.
  4. Grab DJ, Nikolskaia OV, Inoue N, Thekisoe OMM, Morrison LJ, Gibson W, Dumler SJ. Using detergent to enhance detection sensitivity of African trypanosomes in human CSF and blood by Loop-Mediated Isothermal Amplification (LAMP). PLoS Neglected Tropical Diseases 2011 Aug;5(8):e1249.
  5. McTaggart LR, Lei E, Richardson SE, Zhang SX. Rapid identification of Cryptococcus neoformans and Cryptococcus gattii by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS). J Clin Microbiol 2011 Aug;49(8):3050-3.
  6. McTaggart L, Richardson SE, Seah C, Hoang L, Fothergill A, Zhang SX. Rapid identification of Cryptococcus neoformans var. grubii, C. neoformans var. neoformans, and C. gattii using rapid biochemical tests, differential media, and DNA sequencing. J Clin Microbiol 2011 Jul;49(7):2522-7.
  7. Parrish NM, Carroll KC. Role of the clinical Mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings. J Clin Microbiol 2011;49:772-6.
  8. Parrish N, Luethke R, Dionne K, Carroll K, Riedel S. A case of Mycobacterium marinum infection with unusual susceptibility patterns to commonly used antibiotics. J Clin Microbiol 2011 May;49(5):2056-8.
  9. Reller ME, Bodinayake C, Nagahawatte A, Devasiri V, Kodikara-Arachichi W, Strouse JJ, Flom JE, Dumler JS, Woods CW. Leptospirosis as frequent cause of acute febrile illness in southern Sri Lanka. Emerg Infect Dis 2011 Sep;17(9):1678-84.
  10. Reller ME, Clemens EG, Schachterle SE, Mtove GA, Sullivan DJ, Dumler JS. Multiplex 5' nuclease-quantitative PCR for diagnosis of relapsing fever in a large Tanzanian cohort. J Clin Microbiol 2011 Sep;49(9):3245-9.
  11. Riedel S, Eisinger SW, Dam L, Stamper PD, Carroll KC. Comparison of BD Bactec Plus Aerobic/F Medium to VersaTREK Redox 1 blood culture medium for detection of Candida spp. In seeded blood culture specimens containing therapeutic levels of antifungal agents. J Clin Microbiol 2011;49:1524-9.
  12. Riedel S, Melendez JH, An AT, Rosenbaum JE, Zenilman JM. Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department. Am J Clin Pathol 2011 Feb;135:182-9.
  13. Savard P, Gopinath R, Zhu W, Kitchel B, Rasheed JK, Tekle T, Roberts A, Ross T, Razeq J, Landrum BM, Wilson LE, Limbago B, Perl TM, Carroll KC. First NDM-positive Salmonella sp. strain identified in the United States. Antimicrob Agents Chemother 2011;55:5957-8.
  14. Stamper PD, Louie L, Wong H, Simor AE, Farley JE, Carroll KC. Genotypic and phenotypic characterization of methicillin-susceptible Staphylococcus aureus isolates misidentified as methicillin-resistant Staphylococcus aureus by the BD GeneOhm MRSA assay. J Clin Microbiol 2011 Apr;49(4):1240-4.
  15. Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol 2011 Dec;33(8):835-40.
  16. Zhang SX, Rawte P, Brown S, Lo S, Siebert H, Pong-Porter S, Low DE, Jamieson FB. Evaluation of CLSI agar dilution method and trek sensititre broth microdilution panel for determining antimicrobial susceptibility of streptococcus pneumoniae. J Clin Microbiol 2011 Feb;49(2):704-6.

MOLECULAR PATHOLOGY

  1. Daniel J, Coulter J, Woo J-H, Wilsbach K, Gabrielson E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci USA. 2011 Mar;108(13):5384-9.
  2. DeScipio C, Haley L, Beierl K, Pandit AP, Murphy KM, Ronnett BM. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol 2011 Oct;35(10):1586-91.
  3. Harada S, Henderson LB, Eshleman JR, Gocke CD, Burger P, Griffin CA, Batista DA. Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue superior results compared with microsatellite analysis. J Mol Diagn 2011 Sep;13(5):541-8.
  4. Lemmon CR, Woo JH, Tully E, Wilsbach K, Gabrielson E. Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. J Biol Chem 2011 Sep 9;286(36):31457-65.
  5. Li QK, Singh A, Biswal S, Askin F, Gabrielson E. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma. J Hum Genet 2011 Mar;56:230-4.
  6. Lin MT, Tseng LH, Beierl K, Harada S, Hafez MJ, Eshleman JR, Gocke CD. Analysis of hematopoietic stem cell transplant engraftment: use of loss or gain of microsatellite alleles to identify residual hematopoietic malignancy. Diagn Mol Pathol 2011 Dec;20(4):194-202.
  7. Lin MT, Tseng LH, Rich RG, Hafez MJ, Harada S, Murphy KM, Eshleman JR, Gocke CD. Δ-PCR, a simple method to detect translocations and insertion/deletion mutations. J Mol Diagn 2011 Jan;13(1):85-92.
  8. Jinawath N, Zambrano R, Wohler E, Palmquist MK, Hoover-Fong J, Hamosh A, Batista DA. Mosaic trisomy 13: understanding origin using SNP array. J Med Genet 2011 May;48(5):323-6.
  9. McDonald OG, Wu H, Timp W, Feinberg AP. Genome-scale epigenetic reprogramming during epithelial to mesenchymal transition. Nat Struct Mol Biol 2011 Jul 3;18(8):867-74.
  10. Vonderheid EC, Kadin ME, Gocke CD. Lymphomatoid papulosis followed by pityriasis lichenoides: a common pathogenesis? Am J Dermatopathol 2011 Dec;33(8):835-40.
  11. Zambrano RM, Wohler E, Annerén G, Thuresson AC, Cutting GR, Batista DA. Unbalanced translocation 9;16 in two children with dysmorphic features, and severe developmental delay: evidence of cross-over within derivative chromosome 9 in patient #1. Eur J Med Genet 2011 Mar-Apr;54(2):189-93.

NEUROPATHOLOGY

  1. Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Path 2011 Mar;21(2):119-29.
  2. Chiang P-M, Wong PC. Differentiation of an embryonic stem cell to hemogenic endothelium by defined factors: essential role of bone morphogenetic protein-4. Development 2011 July;138:2833-43.
  3. Driscoll D, Troncoso J. Asymptomatic Alzheimer's Disease: a prodrome or a state of resilience? Curr Alzheimer Res 2011 June;8:330-5.
  4. Driscoll D, Troncoso J. Brain resilience and plasticity in the face of Alzheimer Pathology (Editorial). Curr Alzheimer Res 2011 8(4):329.
  5. Eberhart CG. Molecular diagnostics in embryonal brain tumors. Brain Pathol 2011 Jan;21(1):96-104.
  6. Jentoft M, Giannini C, Rossi S, Mota R, Jenkins RB, Rodriguez FJ. Oligodendroglial tumors with marked desmoplasia: clinicopathologic and molecular features of 7 cases. Am J Surg Pathol 2011 Jun;35(6):845-52.
  7. Karafin M, Jallo GI, Ayars M, Eberhart CG, Rodriguez FJ. Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications. Clin Neuropathol 2011 Nov-Dec;30(6):297-300.
  8. Koliatsos VE, Cernak I, Xu Leyan, Song Y, Savonenko A, Crain BJ, Eberhart CG, Frangakis CE, Melnikova T, Kim H, Lee D. A mouse model of blast injury to brain: initial pathological, neuropathological, and behavioral characterization. J Neuropathol & Experimental Neurol 2011 May;70(5);399-416.
  9. Li T, Li Y-M, Ahn K, Price DL, Sisodia SS, Wong P. Increased expression of PS1 is sufficient to elevate the level and activity of γ-secretase in vivo. PLoS ONE 2011 Nov;6(11):e28179.
  10. Lim KJ, Bisht S, Bar EE, Maitra A, Eberhart CG. A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther 2011 Mar 1;11(5):464-73.
  11. O'Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci. 2011;34:185-204.
  12. Orr BA, Bai H, Odia Y, Jain D, Anders RA, Eberhart CG. Yes-associated protein 1 is widely expressed in human brain tumors and promotes glioblastoma growth. J Neuropathol Exp Neurol 2011 Jul;70(7):568-77.
  13. Pierfelice TJ, Schreck KC, Dang L, Asnaghi L, Gaiano N, Eberhart CG. Notch3 activation promotes invasive glioma formation in a tissue site-specific manner. Cancer Res 2011 Feb;71(3):1115-25.
  14. Raabe EH, Lim KS, Kim JM, Meeker A, Mao XG, Nikkhah G, Maciaczyk J, Kahlert U, Jain D, Bar E, Cohen KJ, Eberhart CG. BRAF activation induces transformation and then senescence in human neural stem cells: a pilocytic astrocytoma model. Clin Cancer Res 2011 Jun 1;17(11):3590-9.
  15. Rodriguez EF, Scheithauer BW, Giannini C, Rynearson A, Cen L, Hoesley B, Gilmer-Flynn H, Sarkaria JN, Jenkins S, Long J, Rodriguez FJ. PI3K/AKT pathway alterations are associated with clinically aggressive and histologically anaplastic subsets of pilocytic astrocytoma. Acta Neuropathol 2011 Mar;121(3):407-20.
  16. Rodriguez FJ, Scheithauer BW, George D, Midha R, Maccollin M, Stemmer-Rachamimov AO. Superficial neurofibromas in the setting of schwannomatosis: nosologic implications. Acta Neuropathol. May;121(5):663-8.
  17. Xu L, Shen P, Hazel T, Johe K, Koliatsos VE. Dual transplantation of human neural stem cells into cervical and lumbar cord ameliorates motor neuron disease in SOD1 transgenic rats. Neurosci Lett 2011 May 2;494(3):222-6.

OPHTHALMIC PATHOLOGY

None reported.

SURGICAL PATHOLOGY

  1. Al Hussain T, Carter HB, Epstein JI. Significance of prostate adenocarcinoma perineural invasion on biopsy in patients who are otherwise candidates for active surveillance. J Urol 2011 Aug;186:470-3.
  2. Al Hussain TO, Epstein JI. Initial high grade prostatic intraepithelial neoplasia (HGPIN) with carcinoma on subsequent prostate needle biopsy: findings at radical prostatectomy. Am J Surg Pathol 2011 Aug;35:1165-7.
  3. Amin A, Epstein JI. Pathological stage of prostatic ductal adenocarcinoma at radical prostatectomy: affect of percentage of the ductal component and associated grade of acinar adenocarcinoma. Am J Surg Pathol 2011 Apr;35:615-9.
  4. Amin A, Partin AW, Epstein JI. Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy. J Urol 2011 Oct; 186:1286-90.
  5. Bishop JA, Sharma R, Westra WH. PAX8 immunostaining of anaplastic thyroid carcinoma: a reliable means of discerning thyroid origin for undifferentiated tumors of the head and neck. Hum Pathol 2011 Dec;42(12):1873-7.
  6. Bishop JA, Westra WH. Human papillomavirus-related small cell carcinoma of the oropharynx. Am J Surg Pathol 2011 Nov;35(11):1679-84.
  7. Brimo F, Herawi M, Sharma R, Netto GJ, Epstein JI, Illei PB. Hepatocyte nuclear factor-1β expression in clear cell adenocarcinomas of the bladder and urethra: diagnostic utility and implications for histogenesis. Hum Pathol 2011 Nov;42(11):1613-9.
  8. Chen Y, Epstein JI. Primary carcinoid tumors of the urinary bladder and prostatic urethra: a clininopathologic study of 7 cases. Am J Surg Pathol 2011 Mar;35:442-6.
  9. Chen Y, Fine SW, Epstein JI. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: Findings at radical prostatectomy. Am J Surg Pathol 2011 July;35:1054-61.
  10. Cimino-Mathews A, Lin BM, Chang SS, Boahene KD, Bishop JA. Carcinoma ex pleomorphic adenoma of the nasal cavity. Head Neck Pathol 2011 Dec;5(4):405-9.
  11. Cox R, Epstein JI. Large nested variant of urothelial carcinoma: 23 cases of a newly described entity mimicking von brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma. Am J Surg Pathol 2011 Sept;35:1337-42.
  12. Daniel J, Coulter J, Woo J-H, Wilsbach K, Gabrielson E. High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells. Proc Natl Acad Sci USA. 2011 Mar;108(13):5384–9.
  13. Epstein JI. Prognostic significance of tumor volume in radical prostatectomy and needle biopsy specimens. J Urol 2011 Sept;186:790-7.
  14. Epstein JI. Update on the Gleason grading system. Annales de Pathologie 2011 Nov;31:S20-6.
  15. Fajardo DA, Miyamoto H, Miller JS, Lee TK, Epstein JI. Identification of Gleason pattern 5 on prostatic needle core biopsy: frequency of underdiagnosis and relation to morphology. Am J Surg Pathol 2011 Nov;35(11):1706-11.
  16. Kacar A, Azili MN, Cihan BS, Demir HA, Tiryaki HT, Argani P. Metanephric stromal tumor: a challenging diagnostic entity in children. J Pediatr Surg 2011 Dec;46(12):e7-e10.
  17. Karafin M, Parwani AV, Netto GJ, Illei PB, Epstein JI, Ladanyi M, Argani P. Diffuse expression of PAX2 and PAX8 in the cystic epithelium of mixed epithelial stromal tumor, angiomyolipoma with epithelial cysts, and primary renal synovial sarcoma: evidence supporting renal tubular differentiation. Am J Surg Pathol 2011 Sep;35(9):1264-73.
  18. Karram S, Trock BJ, Netto GJ, Epstein JI. Should intervening benign tissue be included in the measurement of discontinuous foci of cancer on prostate needle biopsy: correlation with radical prostatectomy findings. Am J Surg Pathol 2011 Sept;35:1351-5.
  19. Kryvenko ON, Gupta NS, Meier FA, Lee MW, Epstein JI. Anatomosing hemangioma of the genitourinary system: 8 cases in the kidney and ovary with immunohistochemical and ultrastructural analysis. AJCP 2011 Sept;136:450-7.
  20. Lemmon CR, Woo JH, Tully E, Wilsbach K, Gabrielson E. Nuclear factor-kappaB (NF-kappaB) mediates a protective response in cancer cells treated with inhibitors of fatty acid synthase. J Biol Chem 2011 Sep 9;286(36):31457-65.
  21. Lewis GH, Subhawong AP, Nassar H, Vang R, Park BH, Argani P. Relationship between molecular subtype of invasive breast carcinoma and expression of gross cystic disease fluid protein 15 and mammaglobin. Am J Clin Pathol 2011Apr;135:587-91.
  22. Li QK, Singh A, Biswal S, Askin F, Gabrielson E. KEAP1 gene mutations and NRF2 activation are common in pulmonary papillary adenocarcinoma. J Hum Genet 2011;56:230-4.
  23. Maniar KP, Unger PD, Samadi DB, Xiao GQ. Incidental paraganglia of prostate in radical prostatectomy specimens: a diagnostic pitfall. Int J Surg Pathol Dec 2011:19(6).
  24. Martignoni G, Gobbo S, Camparo P, Brunelli M, Munari E, Segala D, Pea M, Bonetti F, Illei PB, Netto GJ, Ladanyi M, Chilosi M, Argani P. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol 2011 Oct;24(10):1313-9.
  25. Munfus-McCray D, Adams C, Harada S, Askin F, Clark DP, Gabrielson E, Li QK. EGFR and KRAS mutations in metastatic lung adenocarcinomas. Human Pathology. 2011 Oct;42:1447-53.
  26. Nagar M, Epstein JI. Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP). Am J Surg Pathol 2011 June;35:898-903.
  27. Netto GJ, Eisenberger M, Epstein JI. Interobserver variability of histologic evaluation of radical prostatectomy between central and local pathologists: Findings of TAX 3501 multinational clinical trial. Urology 2011 May;77:1155-60.
  28. Singhi AD, Adsay NV, Swierczynski SL, Torbenson M, Anders RA, Hruban RH, Argani P. Hyperplastic luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa. Am J Surg Pathol 2011 Jun;35(6):883-90.
  29. Tan PH, Cheng L, Srigley JR, Griffiths D, Humphrey PA, van der Kwast TH, Montironi R, Wheeler TM, Delahunt B, Egevad L, Epstein JI. ISUP Prostate Cancer Group. International Society of Urological Pathology (ISUP) Consensus Conference on handling and staging of radical prostatectomy specimens. Working group 5. Surgical margins. Mod Pathol 2011 Jan:24:48-57.
  30. Vincent JG,Taube JM. Pigmented extramammary Paget’s disease of the abdomen: a potential mimicker of melanoma. Dermatol Online J 2011 Aug;17(8):13

TRANSFUSION MEDICINE

  1. Cousins MM, Laeyendecker O, Beauchamp G, Brookmeyer R, Towler W, Hudelson S, Khaki L, Koblin B, Chesney M, Moore RD, Kelen GD, Coates T, Quinn TC, Donnell D, Eshleman SH. Use of a high resolution melting (HRM) assay to compare gag, pol, and env diversity in adults with different stages of HIV infection. PLoS One 2011;6(11):e27211.
  2. Eshleman SH, Hudelson S, Redd AD, Wang L, Debes R, Chen YQ, Martens CA, Ricklefs SM, Selig EJ, Porcella SF, S Munshaw, SC Ray, Piwowar-Manning E, et al. Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial. J Infect Dis 2011 Dec;204:1918-26
  3. Fuller AK, Uglik KM, Braine HG, King KE. A comprehensive program to minimize platelet outdating. Transfusion 2011 Jul;51(7):1469-76.
  4. Fogel J, Hoover DR, Sun J, Mofenson LM, Fowler MG, Taylor AW, Kumwenda N, Taha TE, Eshleman SH. Analysis of nevirapine (NVP) resistance in HIV-infected infants who received extended NVP or NVP/zidovudine prophylaxis. AIDS 2011 Apr;25:911-7.
  5. Fogel J, Li Q, Taha TE, Hoover DR, Kumwenda NI, Mofenson LM, Kumwenda JJ, Fowler MG, Thigpen MT, Eshleman SH. Initiation of antiretroviral treatment in women after delivery can induce multi-class drug resistance in breastfeeding HIV-infected infants. Clin Infect Dis 2011 Apr;52:1069-76.
  6. Guo N, Wang J, Ness P, Yao F, Dong X, Bi X, Mei H, Li J, He W, Lu Y, Ma H, Wen X, Huang M, Wright DJ, King M, High P, Nelson K, Shan H; for the NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component. Analysis of Chinese donors' return behavior. Transfusion 2011 Mar;51(3):523-30.
  7. James MM, Wang L, Musoke P, Lidstrom J, Towler WI, Donnell D, Guay LA, Mwatha A, Nakabiito C, Jackson JB, Eshleman SH. Association of HIV diversity and survival in HIV-infected Ugandan infants. PLoS One 2011 Apr;6(4):e18642.
  8. King KE, Ness PM. How do we prevent transfusion-associated graft-versus-host disease in children. Transfusion 2011 May;51:916-20.
  9. Karp JK, Weston CM, King KE. Transfusion medicine in American undergraduate medical education. Transfusion 2011 Nov;51:2470-9.
  10. Ness PM. Does transfusion of stored red blood cells cause clinically important adverse effects? A critical question in search of an answer and a plan. Transfusion 2011 Apr;51(4):666-7.
  11. Onyango-Makumbi C, Omer SB, Mubiru M, Moulton LH, Nakabiito C, Musoke P, Mmiro F, Zwerski S, Wigzell H, Falksveden L, Wahren B, Antelman G, Fowler MG, Guay L, Jackson JB. Safety and efficacy of HIV hyperimmune globulin for prevention of mother-to-child HIV transmission in HIV-1-infected pregnant women and their infants in Kampala, Uganda (HIVIGLOB/NVP STUDY). J Acquir Immune Defic Syndr 2011 Dec 1;58(4):399-407.
  12. Ren FR, Wang JX, Huang Y, Yao FZ, Lv YL, Li JL, Wen GX, Wen XQ, Liu J, Dong XD, Ma HL, Zhou ZM, Bi XH, Tu L, King M, Nelson K, Ness P, Shan H. Hepatitis B virus nucleic acid testing in Chinese blood donors with normal and elevated alanine aminotransferase. Transfusion 2011 Dec;51(12):2588-95.
  13. Rosenbaum L, Tomasulo P, Lipton KS, Ness P. The reintroduction of nonleukoreduced blood: would patients and clinicians agree? Transfusion 2011 Dec;51(12):2739-43
  14. Savage WJ, Barron-Casella E, Fu Z, Dulloor P, Williams L, Crain BJ, White DA, Jennings JM, Van Eyk JE, Debaun MR, Everett A, Casella JF. Plasma glial fibrillary acidic protein levels in children with sickle cell disease. Am J Hematol 2011 May;86(5):427-9.
  15. Savage WJ, Tobian AA, Fuller AK, Wood RA, King KE, Ness PM. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes. Transfusion 2011 Aug;51(8):1716-22.
  16. Taha TE, James MM, Hoover DR, Sun J, Laeyendecker O, Mullis CE, Kumwenda JJ, Lingappa JR, Auvert B, Morrison CS, Mofenson LM, Taylor AT, Fowler MG, Kumwenda NI, Eshleman SH. Association of recent HIV infection and in utero HIV-1 transmission: findings from the PEPI-Malawi trial. AIDS 2011 Jul 17;25(11):1357-64.
  17. Tobian AAR, Gray RH. The male foreskin and oncogenic HPV infection in men and their female partners. Future Microbiol 2011 July;6:739-45.
  18. Tobian AAR, Gray RH. The medical benefits of male circumcision. JAMA 2011;306:1479-80.
  19. Tobian AAR, Kong X, Gravitt PE, Eaton K, Kigozi G, Serwadda D, Oliver AE, Nalugoda F, Makumbi F, Chen MZ, Wawer MJ, Quinn TC, Gray RH. Male circumcision and anatomic sites of penile high-risk human papillomavirus in Rakai, Uganda. Int J Cancer 2011;129:2970-5.
  20. Tobian AAR, Kong X, Wawer MJ, Kigozi G, Gravitt PE, Serwadda D, Eaton K, Nalugoda F, Quinn TC, Gray RH. Circumcision of HIV-infected men and human papillomavirus transmission to female partners: analyses of data from a randomised trial in Rakai, Uganda. Lancet Infectious Diseases 2011 Aug;11(8):604-12.
  21. Tobian AAR, Quinn TC, Gray RH. Male circumcision for prevention of oncogenic HPV infection. Lancet 2011 July;378:314-5.
  22. Tobian AAR, Savage WJ. Book Review: Transfusion Therapy Clinical Principles and Practice. Transfusion 2011 Apr;51:843.
  23. Tobian AAR, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011 Aug;51:1676-83.
  24. Tobian AAR, Shirey RS, King KE. ABO titer monitoring for incompatible renal transplantation. Transfusion 2011 Mar;51:454-7.
  25. Waters JH, Ness PM. Patient blood management: a growing challenge and